- Author: Kathy Keatley Garvey
Newmark, a colonel in the U.S. Army Medical Corps, will be hosted by researcher Bora Inceoglu of the Bruce Hammock lab, UC Davis Department of Entomology and Nematology. The lecture is part of the UC Davis CounterACT Center Seminars for Excellence, Pharmacology Training Grant and Department of Pharmacology (website and list of speakers pending).
According to an entry in Wikipedia:
"Sarin, or GB, is an organophosphorus compound with the formula [(CH3)2CHO]CH3P(O)F. It is a colorless, odorless liquid, used as a chemical weapon owing to its extreme potency as a nerve agent. It has been classified as a weapon of mass destruction in UN Resolution 687. Production and stockpiling of sarin was outlawed by the Chemical Weapons Convention of 1993, and it is classified as a Schedule 1 substance."
"Sarin can be lethal even at very low concentrations, with death following within one minute after direct ingestion due to suffocation from lung muscle paralysis, unless some antidotes, typically atropine or Biperiden and pralidoxime, are quickly administered to a person.People who absorb a non-lethal dose, but do not receive immediate medical treatment, may suffer permanent neurological damage."
Newmark’s credentials include:
- Colonel, Medical Corps, U.S. Army
- Deputy Joint Program Executive Officer, Medical Systems
- Joint Program Executive Office for Chemical/Biological Defense, U.S. Department of Defense
- Consultant to the U.S. Army Surgeon General for Chemical Casualty Care
- Adjunct full professor of neurology, Uniformed Services University of the Health Sciences
- Staff neurologist at Fort Belvoir (Va.) Community Hospital
Newmark received his bachelor’s degree from Harvard College and his medical degree from the College of Physicians and Surgeons of Columbia University. He completed a residency in neurology at the Boston City Hospital and fellowships in neurochemistry at the National Institute of Neurological Disorders and Stroke; in occupational neurology at the Massachusetts General Hospital; and in neuromuscular disease at the University of Pennsylvania.
More information is available from host Bora Inceoglu at abinceoglu@ucdavis.edu or by telephoning (530) 591-0697.
Contact:
Tracey Pirrung
Program Grant Analyst
VM: Molecular Biosciences
University of California, Davis
(530) 754-8157 phone
tapirrung@ucdavis.edu